Systemic effects of inhaled corticosteroids.
作者信息
Monson J P
出版信息
Thorax. 1993 Oct;48(10):955-6. doi: 10.1136/thx.48.10.955.
Abstract
摘要
相似文献
1
Systemic effects of inhaled corticosteroids.吸入性糖皮质激素的全身效应。
Thorax. 1993 Oct;48(10):955-6. doi: 10.1136/thx.48.10.955.
2
[Risks of inhaled glucocorticoids in infantile asthma].
Arch Bronconeumol. 1994 Aug-Sep;30(7):327-30.
3
[Theory and practice with inhalation steroids--systemic effects and side effects].[吸入性类固醇的理论与实践——全身效应和副作用]
Pneumologie. 1991 Mar;45(3):85-9.
4
Inhaled glucocorticoids for asthma.用于哮喘的吸入性糖皮质激素。
N Engl J Med. 1995 Mar 30;332(13):868-75. doi: 10.1056/NEJM199503303321307.
5
Is it time to reduce our phobia of inhaled corticosteroids?是时候减轻我们对吸入性糖皮质激素的恐惧了吗？
Pediatrics. 2004 Jun;113(6):1813-4. doi: 10.1542/peds.113.6.1813.
6
[The secondary effects of inhaled steroids in asthma. New prospects].[吸入性类固醇在哮喘中的次要作用。新前景]
Arch Bronconeumol. 1999 May;35 Suppl 3:15-21.
7
Clinical aspects of anti-inflammatory therapy in asthma.哮喘抗炎治疗的临床方面
Curr Opin Pulm Med. 1996 Jan;2(1):40-7.
8
The safety of inhaled corticosteroids in children.
Prof Nurse. 1997 Nov;13(2):110-2.
9
[Systemic effects of inhaled corticosteroids. Various pending questions].
Acta Med Port. 1997 Nov;10(11):819-24.
10
Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids.吸入性和鼻内用糖皮质激素全身生物活性检测方法
Thorax. 1997 May;52(5):476-82. doi: 10.1136/thx.52.5.476.
引用本文的文献
1
Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate.吸入糖皮质激素治疗的哮喘患者的骨密度：布地奈德与二丙酸倍氯米松的比较。
J R Coll Physicians Lond. 1996 Mar-Apr;30(2):128-32.
2
Glucocorticosteroid treatment of asthma.糖皮质激素治疗哮喘。
Can Fam Physician. 1995 Nov;41:1921-7.
3
New perspectives on inhaled drug delivery and systemic bioactivity.吸入给药与全身生物活性的新视角。
Thorax. 1995 Feb;50(2):105-10. doi: 10.1136/thx.50.2.105.
本文引用的文献
1
Measuring collagen degradation.测量胶原蛋白降解。
Eur J Clin Invest. 1993 Jun;23(6):339-40. doi: 10.1111/j.1365-2362.1993.tb02033.x.
2
Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma.八个月吸入丙酸倍氯米松和布地奈德对成年哮喘患者碳水化合物代谢的影响。
Thorax. 1993 Oct;48(10):974-8. doi: 10.1136/thx.48.10.974.
3
Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects.高剂量吸入性类固醇的全身效应：健康受试者中丙酸倍氯米松与布地奈德的比较。
Thorax. 1993 Oct;48(10):967-73. doi: 10.1136/thx.48.10.967.
4
Adrenocortical function after chronic inhalation of fluocortinbutyl and beclomethasone dipropionate.
Clin Pharmacol Ther. 1981 May;29(5):643-9. doi: 10.1038/clpt.1981.89.
5
Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man.布地奈德和丙酸倍氯米松在人体中的局部和全身糖皮质激素效力。
Eur J Clin Pharmacol. 1982;22(6):523-9. doi: 10.1007/BF00609625.
6
Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma.两种高剂量皮质类固醇气雾剂治疗慢性哮喘的比较：丙酸倍氯米松（每日1500微克）和布地奈德（每日1600微克）
Thorax. 1986 Nov;41(11):869-74. doi: 10.1136/thx.41.11.869.
7
Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects.高剂量吸入丙酸倍氯米松对正常受试者碳水化合物和脂质代谢的影响。
Thorax. 1987 Nov;42(11):881-4. doi: 10.1136/thx.42.11.881.
8
Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency.基础血浆皮质醇测定在垂体-肾上腺功能不全评估中的价值。
Clin Endocrinol (Oxf). 1987 Feb;26(2):221-6. doi: 10.1111/j.1365-2265.1987.tb00780.x.
9
10
Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica.哮喘中的皮质类固醇与骨量：与类风湿关节炎和风湿性多肌痛的比较
Br Med J (Clin Res Ed). 1986 Dec 6;293(6560):1463-6. doi: 10.1136/bmj.293.6560.1463.
Zotero 插件